Navigation Links
Anadys Pharmaceuticals to Present at the Bio CEO & Investor Conference
Date:2/8/2011

statements include, but are not limited to, references to Anadys' strategy, development programs, and ability to develop novel medicines for the treatment of hepatitis C.  Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause Anadys' actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements.  For example, the results of preclinical and early clinical studies may not be predictive of future results, and Anadys cannot provide any assurances that ANA598 or ANA773 will not have unforeseen safety issues, will have favorable results in ongoing or future clinical trials or will receive regulatory approval.  Risk factors that may cause actual results to differ are more fully discussed in Anadys' SEC filings, including Anadys' Form 10-Q for the quarter ended September 30, 2010.  All forward-looking statements are qualified in their entirety by this cautionary statement.  Anadys is providing this information as of this date and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.


'/>"/>
SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Anadys Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference
2. Anadys Pharmaceuticals Initiates Phase IIb Study of ANA598 in HCV Patients
3. Anadys Pharmaceuticals Reports Third Quarter 2010 Financial Results and Highlights
4. Anadys Pharmaceuticals to Report Third Quarter 2010 Financial Results
5. Anadys Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
6. Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences
7. Anadys Pharmaceuticals to Present at the BMO Capital Markets Healthcare Conference
8. Anadys Pharmaceuticals to Report Second Quarter 2010 Financial Results
9. Anadys Retains Lazard as Strategic Advisor
10. Anadys Pharmaceuticals to Present at the ROTH OC Growth Stock Conference
11. Anadys Pharmaceuticals to Present at the Cowen and Company Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... , July 2, 2015 ... as ,Friendly Aedes aegypti , , reduced ... Brazil by 95%, well below ...      (Logo: http://photos.prnewswire.com/prnh/20150630/227348LOGO) , The journal PLOS ... trial of Oxitec,s genetically engineered mosquitoes. The results showed ...
(Date:7/2/2015)... Research and Markets( http://www.researchandmarkets.com/research/nlfg34/cancer ) has announced the ... by Application - Forecast to 2020" report to their offering. ... $13.1 Billion in 2020 from an estimated $7.1 Billion in 2015, ... dominated by North America , followed by ... of the World (RoW). The cancer diagnostics market in ...
(Date:7/2/2015)... Pharma Major Lupin Limited today announced the acquisition of ... subject to certain closing conditions. The acquisition marks ... 765 billion in sales, placing it as one of the ... Health). For over a decade, Russian pharmaceutical market recorded double ... Russia to be one of the ...
Breaking Medicine Technology:Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 2Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 3Global Cancer Diagnostics Market Report 2015 - Technology, Imaging and by Applications Forecasts to 2020 for the $13 Billion Industry 2Lupin Acquires Biocom in Russia 2Lupin Acquires Biocom in Russia 3
... 1, 2011 Hologic, Inc. (NASDAQ: HOLX ) ... Financial Officer, will be presenting at the Nasdaq OMX 27th ... 11:15am (GMT). Interested parties are invited to listen ... the investor section of Hologic,s website at www.hologic.com/investors-overview . ...
... Md., Dec. 1, 2011 The Food and Drug Administration ... products, including a potentially contaminated nasal spray ... unapproved drug sold as a testosterone booster ... alerts were prompted by reports FDA received from health care ...
Cached Medicine Technology:
(Date:7/3/2015)... ... 03, 2015 , ... First Choice Emergency Room , the largest network ... as the new Medical Director of its Frisco facility. , “We are pleased to ... said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:7/3/2015)... ... July 03, 2015 , ... Yisrayl Hawkins, Pastor and ... this week that he says will reveal biblical truth and expose popular lies regarding ... Your Bible Say Don’t Have Sex”, immediately goes into the core of the subject ...
(Date:7/3/2015)... ... 2015 , ... The Celebrity Dresses is currently running a promotion through July ... will have the opportunity to get 10% discount on orders that are over $100. ... have to use coupon codes or remember redemption codes. , There is a ...
(Date:7/2/2015)... ... July 02, 2015 , ... sweetFrog Enterprises, LLC. is pleased to announce the opening of its ... the Lone Star State. The premium frozen yogurt chain was listed as #22 on the ... 19 in the Village at Bachman Lake, is located at:, 3701 W. Northwest Highway, STE ...
(Date:7/2/2015)... ... ... Following the recent report by JAMA Internal Medicine published on ... Samir Becic emphatically declared a war on obesity in the United States. , "Obesity ... must understand the magnitude of this discovery. For that reason, I am declaring, along ...
Breaking Medicine News(10 mins):Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 3Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2Health News:Celebrity Fashion Summer Party Dresses on sale at TheCelebrityDresses.com 2Health News:sweetFrog Opens 18th Location in the Lone Star State 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 3Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 4
... by a jackal in Bihar's Gopalganj district, but there are ... patients. ,In the last two days, ... and children - in half a dozen villages under the ... ,The injured are being treated at different hospitals ...
... bio-technology pharma company from Zurich, Switzerland has developed a ... months at a time . ,The drug ... blood pressure by contracting vessels, by inducing antibodies. ... CYT006-AngQb developed by Cytos Biotechnology reduced systolic blood pressure ...
... in that US doctors tend to prescribe unwanted, even possibly ... the name of lecture assignments. ,Lawmakers are ... to disclose payments made to doctors and also keep within ... earn more money from drug makers than doctors in any ...
... heiress Paris Hilton under house arrest, has defended his ... from a 'life-threatening' psychiatric condition called decompensating. ... mental state to the point of severe depression, nervousness ... Simple Life star's condition was even more complicated because ...
... Louis University has found that a patient's emotional state plays ... surgery. ,After hip surgery, two tests are ... is a clinical measure of hip function given by the ... considers a wide variety of factors in determining the overall ...
... at the University of York and Hull York Medical School ... folate. ,Folate is a vitamin that comes ... and peas. Fortified cereal products, sunflower seeds as well as ... been claiming that adding folate to bread or flour will ...
Cached Medicine News:Health News:US Lawmakers Considering Legislation to Restrict Payments by Drug Companies to Doctors 2Health News:US Lawmakers Considering Legislation to Restrict Payments by Drug Companies to Doctors 3Health News:Emotions Play 'significant Role' in Recovery from Hip Surgery 2
... Get the equivalent of 7.5 liters out ... will you need two machines for your high-flow ... OXYMIZER Disposable Oxygen-Conserving Devices function like standard conservers, ... flow of oxygen required to saturate a patient. ...
Lightweight Pneumatic Conserver., ,NOTE: All models passed the ASTM PS 127-00 regulator ignition safety test....
Lightweight Pneumatic Conserver., ,NOTE: All models passed the ASTM PS 127-00 regulator ignition safety test....
... an average 5:1 increase in usage time at ... a standard cannula. , ,The combination of ... oxygen patients a superior alternative to liquid oxygen. ... , ,NOTE: Each ...
Medicine Products: